GPR143 mutations in Chinese patients with ocular albinism type 1

Jia,Xiuhua; Yuan,Jin; Jia,Xiaoyun; Ling,Shiqi; Li,Shiqiang; Guo,Xiangming

doi:10.3892/mmr.2017.6366

GPR143 mutations in Chinese patients with ocular albinism type 1

Authors:
- Xiuhua Jia
- Jin Yuan
- Xiaoyun Jia
- Shiqi Ling
- Shiqiang Li
- Xiangming Guo
View Affiliations

Affiliations: Department of Ophthalmology, The Third Affiliated Hospital, Sun Yat‑sen University, Guangzhou, Guangdong 510630, P.R. China, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat‑sen University, Guangzhou, Guangdong 510060, P.R. China
Published online on: March 23, 2017 https://doi.org/10.3892/mmr.2017.6366
Pages: 3069-3075
Copyright: © Jia et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to evaluate mutations of the G protein-coupled receptor 143 (GPR143) gene for ocular albinism type 1 (OA1) in Chinese patients. For the current study, 8 patients with OA1 were selected from the database of ocular genetic diseases. Genomic DNA of OA1 was prepared from venous leukocytes collected from the patients. Cycle sequencing was used to analyze the exons and adjacent introns of GPR143. The variation detected was analyzed by bidirectional DNA sequencing and further evaluated in 96 controls using heteroduplex‑single strand conformational polymorphism analysis. Additionally, slit lamp photography of anterior segment, fundus photography and optical coherence tomography (OCT) were performed to identify the clinical features of OA1. In five patients with OA1, 5 GPR143 gene mutations were identified and four of them there were novel mutations. The screening rate is 62.5%, including c.333G>A (p.W111X), c.353G>A (p.G118E) (known mutation), C.658+2T>G (splice mutation), c.215_216insCGCTGC (p.71‑72insAA) and c.17T>C (p. L6P). These mutations were absent in the 96 normal controls. Only one patient with OA1 in the present study was female. Patients with OA1 often have congenital nystagmus, refractive error, severe decline of visual acuity (from 0.1 to 0.4) and foveal hypoplasia. Different degrees of pigment loss were evident in the patients' iris and retina, whereas macular structure was not identified in the OCT examination. The findings of the present study expanded the gene mutation spectrum of GPR143 and investigated the clinical phenotype of patients with OA1 in the Chinese population. Additional evidence for clinical diagnosis was provided along with differential diagnosis and genetic counseling.

View Figures

View References

1	Schnur RE, Gao M, Wick PA, Keller M, Benke PJ, Edwards MJ, Grix AW, Hockey A, Jung JH, Kidd KK, et al: OA1 mutations and deletions in X-linked ocular albinism. Am J Hum Genet. 62:800–809. 1998. View Article : Google Scholar : PubMed/NCBI
2	Rosenberg T and Schwartz M: X-linked ocular albinism: Prevalence and mutations-a national study. Eur J Hum Genet. 6:570–577. 1998. View Article : Google Scholar : PubMed/NCBI
3	O'Donnell FE Jr, King RA, Green WR and Witkop CJ Jr: Autosomal recessively inherited ocular albinism. A new form of ocular albinism affecting females as severely as males. Arch Ophthalmol. 96:1621–1625. 1978. View Article : Google Scholar : PubMed/NCBI
4	Cortin P, Tremblay M and Lemagne JM: X-linked ocular albinism: Relative value of skin biopsy, iris transillumination and funduscopy in identifying affected males and carriers. Can J Ophthalmol. 16:121–123. 1981.PubMed/NCBI
5	Lam BL, Fingert JH, Shutt BC, Singleton EM, Merin LM, Brown HH, Sheffield VC and Stone EM: Clinical and molecular characterization of a family affected with X-linked ocular albinism (OA1). Ophthalmic Genet. 18:175–184. 1997. View Article : Google Scholar : PubMed/NCBI
6	Sallmann GB, Bray PJ, Rogers S, Quince A, Cotton RG and Carden SM: Scanning the ocular albinism 1 (OA1) gene for polymorphisms in congenital nystagmus by DHPLC. Ophthalmic Genet. 27:43–49. 2006. View Article : Google Scholar : PubMed/NCBI
7	Schiaffino MV, d'Addio M, Alloni A, Baschirotto C, Valetti C, Cortese K, Puri C, Bassi MT, Colla C, De Luca M, et al: Ocular albinism: Evidence for a defect in an intracellular signal transduction system. Nat Genet. 23:108–112. 1999. View Article : Google Scholar : PubMed/NCBI
8	Samaraweera P, Donatien PD, Qazi S, Kobayashi T, Hearing VJ, Panthier JJ and Orlow SJ: Identification and characterization of a melanocyte-specific novel 65-kDa peripheral membrane protein. Eur J Biochem. 266:924–934. 1999. View Article : Google Scholar : PubMed/NCBI
9	d'Addio M, Pizzigoni A, Bassi MT, Baschirotto C, Valetti C, Incerti B, Clementi M, De Luca M, Ballabio A and Schiaffino MV: Defective intracellular transport and processing of OA1 is a major cause of ocular albinism type 1. Hum Mol Genet. 9:3011–3018. 2000. View Article : Google Scholar : PubMed/NCBI
10	Yan J and Dennin RH: High homologous nucleotide to GBV-C was amplified from DNA of MT2 and HeLa cells and PBMC of human and chimpanzee. Acta Pharmacol Sin. 22:320–326. 2001.PubMed/NCBI
11	Zhang Q and Minoda K: Detection of congenital color vision defects using heteroduplex-SSCP analysis. Jpn J Ophthalmol. 40:79–85. 1996.PubMed/NCBI
12	Stone EM: Leber congenital amaurosis-a model for efficient genetic testing of heterogeneous disorders: LXIV edward jackson memorial lecture. Am J Ophthalmol. 144:791–811. 2007. View Article : Google Scholar : PubMed/NCBI
13	Sale MM, Craig JE, Charlesworth JC, FitzGerald LM, Hanson IM, Dickinson JL, Matthews SJ, Heyningen Vv, Fingert JH and Mackey DA: Broad phenotypic variability in a single pedigree with a novel 1410delC mutation in the PST domain of the PAX6 gene. Hum Mutat. 20:3222002. View Article : Google Scholar : PubMed/NCBI
14	Giordano F, Bonetti C, Surace EM, Marigo V and Raposo G: The ocular albinism type 1 (OA1) G-protein-coupled receptor functions with MART-1 at early stages of melanogenesis to control melanosome identity and composition. Hum Mol Genet. 18:4530–4545. 2009. View Article : Google Scholar : PubMed/NCBI
15	Bassi MT, Bergen AA, Bitoun P, Charles SJ, Clementi M, Gosselin R, Hurst J, Lewis RA, Lorenz B, Meitinger T, et al: Diverse prevalence of large deletions within the OA1 gene in ocular albinism type 1 patients from Europe and North America. Hum Genet. 108:51–54. 2001. View Article : Google Scholar : PubMed/NCBI
16	Schiaffino MV, Bassi MT, Galli L, Renieri A, Bruttini M, De Nigris F, Bergen AA, Charles SJ, Yates JR, Meindl A, et al: Analysis of the OA1 gene reveals mutations in only one-third of patients with X-linked ocular albinism. Hum Mol Genet. 4:2319–2325. 1995. View Article : Google Scholar : PubMed/NCBI
17	Rudolph G, Meindl A, Bechmann M, Schworm HD, Achatz H, Boergen KP, Kampik A, Berninger T and Meitinger T: X-linked ocular albinism (Nettleship-Falls): A novel 29-bp deletion in exon 1. Carrier detection by ophthalmic examination and DNA analysis. Graefes Arch Clin Exp Ophthalmol. 239:167–172. 2001. View Article : Google Scholar : PubMed/NCBI
18	Sone M and Orlow SJ: The ocular albinism type 1 gene product, OA1, spans intracellular membranes 7 times. Exp Eye Res. 85:806–816. 2007. View Article : Google Scholar : PubMed/NCBI
19	Camand O, Boutboul S, Arbogast L, Roche O, Sternberg C, Sutherland J, Levin A, Héon E, Menasche M, Dufier J and Abitbol M: Mutational analysis of the OA1 gene in ocular albinism. Ophthalmic Genet. 24:167–173. 2003. View Article : Google Scholar : PubMed/NCBI
20	O'Donnell FE Jr, Green WR, Fleischman JA and Hambrick GW: X-linked ocular albinism in Blacks. Ocular albinism cum pigmento. Arch Ophthalmol. 96:1189–1192. 1978. View Article : Google Scholar : PubMed/NCBI
21	Shiono T, Tsunoda M, Chida Y, Nakazawa M and Tamai M: X linked ocular albinism in Japanese patients. Br J Ophthalmol. 79:139–143. 1995. View Article : Google Scholar : PubMed/NCBI